The Public Awareness of the Prevalence and Impact of Irritable Bowel Syndrome in the United States: Perception Versus Reality

Journal of Clinical Gastroenterology

Volumn 38, Issue 5, 2004, Pages 419-424

  Verne, G Nicholas ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Abdominal pain; Constipation; Diarrhea; Irritable bowel syndrome

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; IRRITABLE COLON; MALE; MIDDLE AGED; PREVALENCE; PUBLIC OPINION; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; PUBLIC OPINION; QUESTIONNAIRES; UNITED STATES;

EID: 4344602665     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-200405000-00006     Document Type: Article

References (36)

1. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45:II43-II47.
2. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995;122:107-112.
3. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med. 1999;107:12S-19S.
4. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11:3-15.
5. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:371-384.
6. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
7. Saito YA, Schoenfeld P, Locke GR Iii. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910-1915.
8. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120-2137.
9. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97:S1-S5.
10. Centers for Disease Control and Prevention. Summary Health Statistics for US adults: National Health Interview Survey, 1998. Atlanta, GA: Department of Health and Human Services Vital and Health Statistics; 2002:1-114.
11. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282-1284.
12. International Foundation for Functional Gastrointestinal Disorders. IBS in the Real World Survey. Milwaukee, WI: International Foundation for Functional Gastrointestinal Disorders; 2002:1-19.
13. Mayer EA, Naliboff B, Lee O, et al. Review article: gender-related differences in functional gastrointestinal disorders. Aliment Pharmacol Ther. 1999;13:65-69.
14. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-2131.
15. Silk DB. Impact of irritable bowel syndrome on personal relationships and working practices. Eur J Gastroenterol Hepatol. 2001;13:1327-1332.
16. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol. 1999;94:1320-1326.
17. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654-660.
18. Frank L, Kleinman L, Rentz A, et al. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675-689.
19. Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553-559.
20. Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care. 2001;7:S268-S275.
21. American Gastroenterological Association. The Burden of Gastrointestinal Diseases. Bethesda, Md: American Gastroenterological Association; 2001:1-86. Available at:
22. Ricci JF, Jhingran P, McLaughlin T, et al. Costs of care for irritable bowel syndrome in managed care. J Clin Outcomes Manag. 2000;7:23-28.
23. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-818.
24. American Heart Association. American Heart Association Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2002:1-35.
25. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol. 2001;96:3122-3129.
26. Hungin APS, Tack J, Mearin F, et al. Irritable bowel syndrome (IBS): prevalence and impact in the USA—the truth in IBS (T-IBS) survey [abstract]. Am J Gastroenterol. 2002;97:S280-S281.
27. GlaxoWellcome. IBS in American Women: A Landmark Survey. Research Triangle Park, NC: GlaxoWellcome; 1999:1-9.
28. Irritable bowel syndrome: practitioner awareness, patient education can limit utilization. Dis Manag Advis. 2002;8:177,185-187.
29. O’Sullivan MA, Mahmud N, Kelleher DP, et al. Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2000;12:39-43.
30. Mahmood Z, Scheuner S, Gamborone J, et al. Knowledge of the irritable bowel syndrome in patients and the general public [abstract]. Irish J Med Sci. 1997;166:15.
31. Druss BG, Marcus SC, Olfson M, et al. Comparing the national economic burden of five chronic conditions. Health Aff. 2001;20:233-241.
32. Dancey CP, Backhouse S. Towards a better understanding of patients with irritable bowel syndrome. J Adv Nurs. 1993;18:1443-1450.
33. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97:S7-S26.
34. Rosemore JG, Lacy BE. Irritable bowel syndrome: basis of clinical management strategies. J Clin Gastroenterol. 2002;35:S37-S44.
35. Zelnorm. (tegaserod maleate). Prescribing information. East Hanover, NJ: Novartis Pharmaceuticals; 2002.
36. Lotronex. (alosetron hydrochloride). Prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2002.